Maria Gisella Cavallo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes	ACTA DIABETOLOGICA	2022
CAPTURE: A cross-sectional study on the prevalence of cardiovascular disease in adults with type 2 diabetes in Italy	NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES	2022
New Insights in the Control of Fat Homeostasis: The Role of Neurotensin	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
High pro-neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow-up	ACTA DIABETOLOGICA	2022
Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis	BIOMEDICINES	2022
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes	DIABETES & METABOLISM	2022
Circulating pro-neurotensin levels predict bodyweight gain and metabolic alterations in children	NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES	2021
The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up study	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION	2021
Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus	BOOK OF ABSTRACTS - FEBS PARP2021 ADVANCED COURSE PARP: Research on the family of poly(ADP-ribose) polymerases, 7 - 10 September 2021 Barcelona, Spain	2021
Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus	CLINICAL EPIGENETICS	2021
Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control	LIFE SCIENCES	2021
The rs45454496 (E1813K) variant in the adiposity gene ANK2 doesn't associate with obesity in Southern European subjects	GENE REPORTS	2021
Expression of TGR5 in adipose tissue in relation to metabolic impairment and adipose tissue dysfunction in human obesity	METABOLISM AND TARGET ORGAN DAMAGE	2021
Expression of TGR5 in adipose tissue in relation to metabolic impairment and adipose tissue dysfunction in human obesity	METABOLISM AND TARGET ORGAN DAMAGE	2021
COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications	DIABETES RESEARCH AND CLINICAL PRACTICE	2020
Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION	2020
Association of Apelin Levels in Overweight-obese Children with Pubertal Development, but Not with Insulin Sensitivity: 6.5 Years Follow up Evaluation	ENDOCRINE RESEARCH	2020
Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease	DIABETES/METABOLISM RESEARCH AND REVIEWS	2020

Progetti di Ricerca

Investigating the expression of the Takeda G-protein-coupled receptor 5 (TGR5) in visceral adipose tissue in relation to insulin-resistance related disease and adipose tissue dysfunction in human obesity
DPP-4 activity in inflammation and bone metabolism: role of the DPP-4 in Vitamin D balance and bone health in relation to glucose metabolism and other metabolic complications of obesity
From chronic inflammation to metabolic disorders: study of the gut-liver axis in the pathophysiology of adipose tissue dysfunction

Gruppi di ricerca

Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection